Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
New words:
Acrux, afflicted, alleviate, alleviation, America, analytical, avanafil, avanfil, baby, billion, boomer, borrow, borrowing, candidate, capacity, chance, chart, computation, credit, crossover, DDS, drawn, dry, EPS, estradiol, expertise, fast, FDA, Fempharm, filling, focused, Fornier, found, founded, genital, GlaxoSmithKlineBeecham, grow, handheld, healthy, high, hot, hypoactive, interaction, invisible, Lauman, leader, lifestyle, low, lubrication, Melbourne, menopausal, menopause, Metered, middle, milestone, model, Mountain, negative, NeraPharm, onset, overhead, payable, penetration, plant, plasma, prevalent, Pty, published, purpose, range, removal, replenish, revolutionized, scientific, Senetek, sequence, showed, simple, skin, specialty, spol, spontaneity, spray, strong, testosterone, theJournal, today, transdermal, underserved, unmet, View, washing, yield
Removed:
accretion, acquiring, active, activity, Addendum, adjusted, adjustment, administering, ADP, advanced, Africa, agent, aggressively, agreed, ALIBRA, Alternate, amortization, amortized, amount, arbitration, arrangement, asserted, assigned, assignee, assured, ASTRAZ, AstraZeneca, attributed, August, Austria, awarded, awarding, aware, baseline, Belgium, billed, Britain, buccal, building, buying, Caliper, Canadian, capable, channel, cheek, Chicago, China, Cilag, classified, collectibility, complementary, component, constructed, Cristina, criteria, damaged, declining, defective, deferred, delivered, denied, Denmark, depicted, derive, deriving, determinable, determined, device, diligence, directed, discussed, dispersed, distributor, division, dosage, Dr, East, ejaculation, estimate, evaluating, evidence, excluding, expand, expanded, expire, Fairchild, final, finalization, Finland, forecasted, foundation, France, Frazier, Germany, Great, Greece, gum, hearing, hydrophilic, identification, impacted, improvement, Invemed, invested, Ireland, Italy, Janssen, Japan, Kepner, Kock, Korea, licensee, longer, lost, lowest, Luxembourg, maintenance, marketplace, Marshall, mcg, measured, met, Mexico, multiple, NDA, Nera, nitroglycerin, ointment, orgasm, originally, panel, patentable, PDE, pending, persuasive, Pharm, Pharmaceutica, pharmacokinetic, pharmacologic, placebo, policy, Porex, Portugal, post, postmenopausal, potent, practice, premature, prevention, pricing, pursue, pursuing, ratably, realized, recent, recently, recognized, relationship, representing, resolution, response, restoring, return, revision, rigidity, Romania, securing, separate, sought, South, Spain, stated, statistically, sterilize, stimulation, strategic, strength, sublingual, submitted, subsequently, succeed, Sweden, Synergy, targeted, thousand, title, tolerated, tongue, transferred, transmucosal, transurethrally, treated, ultimately, unasserted, underneath, unearned, unfavorable, unrealized, updated, urethra, vasoactive, vehicle, vigorously, Virgil, visual, warehousing, Warrant, wholesaler, withdrew
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.42 Amendment One to Agreement Dated 1/9/2004
- 10.50 Testosterone Agreement
- 10.51 Estradiol Agreement
- 10.52 Note Purchase Agreement
- 10.53 Manufacture and Supply Agreement
- 31.1 Section 302 Certification of C.e.o.
- 31.2 Section 302 Certification of C.f.o.
- 32 Section 906 Certification of C.e.o. and C.f.o.
VVUS similar filings
Filing view
External links